Occipital Transcutaneous Stimulation in Chronic Migraine (OSCRO)

University of Liege

Status and phase: Unknown; Phase 4

Conditions: Chronic Migraine

Treatments: Device: Cefaly Kit Arnold

Study type: Interventional

Funder types: Other

Identifiers

NCT02307071

OTSCM

Details and patient eligibility

About

This study evaluates the effect in chronic migraine patients of daily 20 minute-transcutaneous sub occipital neurostimulation using the occipital Cefaly° device.

Full description

Chronic migraine is a disabling neurological condition affecting 0.5-2% of the population.

CM is difficult to treat and preventive treatment options are limited. Due to the inefficiency of available and the lack of new preventive anti-migraine drug, neurostimulation methods have raised great interest in recent years.

The ONSTIM study showed a reduction in headache frequency in 39% of patients treated with active ONS during 12 weeks, compared to no improvement in the "non-effectively" stimulated or medically treated groups.

Enrollment: 20 estimated patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• diagnosis of chronic migraine (ICHD III beta 1.3) with or without medication overuse

Exclusion criteria

• other diseases

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

20 participants in 1 patient group

Cefaly Kit Arnold

Experimental group

Description:

Occipital transcranial stimulation is implemented in occipital region at 16 mA of intensity, for 20 minutes, everyday for 3 months, in 20 chronic migraine patients.

Treatment:

Device: Cefaly Kit Arnold